Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 426

1.

Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study.

Rahman M, Yang W, Akkina S, Alper A, Anderson AH, Appel LJ, He J, Raj DS, Schelling J, Strauss L, Teal V, Rader DJ; CRIC Study Investigators.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1190-8. doi: 10.2215/CJN.09320913. Epub 2014 May 15.

2.

Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.

Yang W, Xie D, Anderson AH, Joffe MM, Greene T, Teal V, Hsu CY, Fink JC, He J, Lash JP, Ojo A, Rahman M, Nessel L, Kusek JW, Feldman HI; CRIC Study Investigators.

Am J Kidney Dis. 2014 Feb;63(2):236-43. doi: 10.1053/j.ajkd.2013.08.028. Epub 2013 Oct 30.

3.

Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function.

Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, Townsend RR, Xie D, Cifelli D, Cohan J, Fink JC, Fischer MJ, Gadegbeku C, Hamm LL, Kusek JW, Landis JR, Narva A, Robinson N, Teal V, Feldman HI; Chronic Renal Insufficiency Cohort (CRIC) Study Group.

Clin J Am Soc Nephrol. 2009 Aug;4(8):1302-11. doi: 10.2215/CJN.00070109. Epub 2009 Jun 18. Erratum in: Clin J Am Soc Nephrol. 2011 Oct;6(10):2548-53.

4.

Impact of the Triglycerides to High-Density Lipoprotein Cholesterol Ratio on the Incidence and Progression of CKD: A Longitudinal Study in a Large Japanese Population.

Tsuruya K, Yoshida H, Nagata M, Kitazono T, Iseki K, Iseki C, Fujimoto S, Konta T, Moriyama T, Yamagata K, Narita I, Kimura K, Kondo M, Asahi K, Kurahashi I, Ohashi Y, Watanabe T.

Am J Kidney Dis. 2015 Dec;66(6):972-83. doi: 10.1053/j.ajkd.2015.05.011. Epub 2015 Jul 2.

PMID:
26145254
5.

Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.

Dobre M, Yang W, Chen J, Drawz P, Hamm LL, Horwitz E, Hostetter T, Jaar B, Lora CM, Nessel L, Ojo A, Scialla J, Steigerwalt S, Teal V, Wolf M, Rahman M; CRIC Investigators.

Am J Kidney Dis. 2013 Oct;62(4):670-8. doi: 10.1053/j.ajkd.2013.01.017. Epub 2013 Mar 13.

6.

Statins for treatment of dyslipidemia in chronic kidney disease.

Shurraw S, Tonelli M.

Perit Dial Int. 2006 Sep-Oct;26(5):523-39. Review.

PMID:
16973506
7.

Progression of pediatric CKD of nonglomerular origin in the CKiD cohort.

Fathallah-Shaykh SA, Flynn JT, Pierce CB, Abraham AG, Blydt-Hansen TD, Massengill SF, Moxey-Mims MM, Warady BA, Furth SL, Wong CS.

Clin J Am Soc Nephrol. 2015 Apr 7;10(4):571-7. doi: 10.2215/CJN.07480714. Epub 2015 Jan 29.

8.

Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency.

Samuelsson O, Mulec H, Knight-Gibson C, Attman PO, Kron B, Larsson R, Weiss L, Wedel H, Alaupovic P.

Nephrol Dial Transplant. 1997 Sep;12(9):1908-15.

PMID:
9306342
9.

Acute effects of fructose consumption on uric acid and plasma lipids in patients with impaired renal function.

Zawiasa A, Nowicki M.

Metabolism. 2013 Oct;62(10):1462-9. doi: 10.1016/j.metabol.2013.05.020. Epub 2013 Jul 15.

PMID:
23866980
10.

Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHAT.

Rahman M, Baimbridge C, Davis BR, Barzilay JI, Basile JN, Henriquez MA, Huml A, Kopyt N, Louis GT, Pressel SL, Rosendorff C, Sastrasinh S, Stanford C; ALLHAT Collaborative Research Group.

Clin Nephrol. 2013 Oct;80(4):235-48. doi: 10.5414/CN107922.

11.

Non-HDL-cholesterol to HDL-cholesterol ratio as an independent risk factor for the development of chronic kidney disease.

Zuo PY, Chen XL, Liu YW, Zhang R, He XX, Liu CY.

Nutr Metab Cardiovasc Dis. 2015 Jun;25(6):582-7. doi: 10.1016/j.numecd.2015.03.003. Epub 2015 Mar 13.

PMID:
25921842
12.

Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study.

Boes E, Fliser D, Ritz E, König P, Lhotta K, Mann JF, Müller GA, Neyer U, Riegel W, Riegler P, Kronenberg F.

J Am Soc Nephrol. 2006 Feb;17(2):528-36. Epub 2005 Dec 28.

13.

Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency.

Samuelsson O, Attman PO, Knight-Gibson C, Larsson R, Mulec H, Weiss L, Alaupovic P.

J Am Soc Nephrol. 1998 Aug;9(8):1482-8.

14.

High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease.

Baragetti A, Norata GD, Sarcina C, Rastelli F, Grigore L, Garlaschelli K, Uboldi P, Baragetti I, Pozzi C, Catapano AL.

J Intern Med. 2013 Sep;274(3):252-62. doi: 10.1111/joim.12081. Epub 2013 May 11.

15.

Retinopathy and progression of CKD: The CRIC study.

Grunwald JE, Pistilli M, Ying GS, Daniel E, Maguire MG, Xie D, Whittock-Martin R, Parker Ostroff C, Lo JC, Townsend RR, Gadegbeku CA, Lash JP, Fink JC, Rahman M, Feldman HI, Kusek JW; Chronic Renal Insufficiency Cohort Study Investigators.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1217-24. doi: 10.2215/CJN.11761113. Epub 2014 May 8.

16.

Association of the triglycerides to high-density lipoprotein cholesterol ratio with the risk of chronic kidney disease: analysis in a large Japanese population.

Tsuruya K, Yoshida H, Nagata M, Kitazono T, Hirakata H, Iseki K, Moriyama T, Yamagata K, Yoshida H, Fujimoto S, Asahi K, Kurahashi I, Ohashi Y, Watanabe T.

Atherosclerosis. 2014 Mar;233(1):260-7. doi: 10.1016/j.atherosclerosis.2013.12.037. Epub 2014 Jan 18.

PMID:
24529154
17.

Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria.

Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S.

Kidney Int. 2002 Nov;62(5):1743-9.

18.

Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.

Samuelsson O, Attman PO, Knight-Gibson C, Kron B, Larsson R, Mulec H, Weiss L, Alaupovic P.

Nephron. 1997;75(3):286-94.

PMID:
9069450
19.

Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study.

Foster MC, Coresh J, Hsu CY, Xie D, Levey AS, Nelson RG, Eckfeldt JH, Vasan RS, Kimmel PL, Schelling J, Simonson M, Sondheimer JH, Anderson AH, Akkina S, Feldman HI, Kusek JW, Ojo AO, Inker LA; CKD Biomarker Consortium and the CRIC Study Investigators.

Am J Kidney Dis. 2016 Jul;68(1):68-76. doi: 10.1053/j.ajkd.2016.01.015. Epub 2016 Mar 3.

20.

Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.

Shoji T, Nishizawa Y, Kawagishi T, Tanaka M, Kawasaki K, Tabata T, Inoue T, Morii H.

Atherosclerosis. 1997 Jun;131(2):229-36.

PMID:
9199276

Supplemental Content

Support Center